ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
22.91
+0.10 (0.44%)
At close: Jun 27, 2025, 4:00 PM
22.91
0.00 (0.00%)
After-hours: Jun 27, 2025, 5:59 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $783.81 million as of June 27, 2025. Its market cap has increased by 26.02% in one year.
Market Cap
783.81M
Enterprise Value
601.71M
1-Year Change
26.02%
Ranking
Category
Stock Price
$22.91
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $783.81M, an increase of 36.26%. That is a compound annual growth rate of 24.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 780.39M | -13.07% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.78B |
| Johnson & Johnson | 367.26B |
| AbbVie | 328.18B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.32B |
| Abbott Laboratories | 239.63B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |